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Richard J. Mazzaccaro, MD, PhD, Department of Pediatrics; Michael J. Weiss, MPH, Network Office of Research and Innovation
Purpose:
In 2011, the American Academy of Pediatrics 
(AAP) revised its Urinary Tract Infection (UTI) clinical 
practice guideline1.  A significant change to prior 
practice is the recommendation of a renal ultrasound 
(RUS) to determine whether to perform a voiding 
cystourethrogram (VCUG) for detection of vesicoureteral 
reflux (VUR) after initial UTI in infants 2-24 months old.  
The new recommendation has generated controversy, 
however, due to concerns that the RUS is not an ideal 
screening tool for detecting VUR2,3,4,5, which may lead 
to potential delays in diagnosis of VUR, recurrence of 
UTI, and the possibility of renal scarring and long-term 
renal disease. 
Additionally, the current AAP recommendation applies 
only to infants 2-24 months old and few studies have 
focused on neonates 0-2 months of age6.  It is unclear 
if predictive characteristics of RUS can or should be 
applied to infants 0-2 months old presenting with a first 
episode of UTI.  
Methods:
•		We conducted an IRB-approved, retrospective 
chart review of 91 infants 0-24 months of age who 
were admitted to the inpatient pediatrics unit with a 
diagnosis of first UTI between January 1, 2006 and 
December 31, 2010.  
•		All infants had a RUS and VCUG.  
•		Sensitivity, specificity, positive and negative predictive 
values were calculated for the ability of a non-normal 
RUS to predict VUR.  Specific analyses distinguished 
between grades of detected VUR, as well as subject 
age.
Table 2. Performance Characteristics of a RUS in Detecting Varying Grades 








0-2 Months Old (n=39)    
   Any VUR 57.1 19.1 46.9 83.3
   Grade III, IV, V VUR Only 60 14.3 47.1 88.9
   Grade IV or V VUR Only 100 14.3 50 100
2-24 Months Old (n=52)
   Any VUR 33.3 31.2 70.3 72.2
   Grade III, IV, V VUR Only 37.5 18.6 70.5 86.1
   Grade IV or V VUR Only 100 6.3 70.6 100
Study Objectives:
The objective of this study was to evaluate the 
effectiveness of a RUS as a screening tool for detecting 
VUR in neonates and infants after initial UTI.
Results:
•	 	Ninety-one infants, including 39 neonates (5 days to 2 months old), 
admitted with first episode of UTI were included in our study.  
•	 	Most of the infants in our study had culture-confirmed UTI (87%) following 
objective signs of infection (fever in 90%) and appropriate urine collection 
methods (81%). Table 1 summarizes the characteristics of the infants in 
this study.
•	 	Overall, 37% of our study group had a RUS reading other than normal (i.e. 
renal fullness, pelviectasis, hydronephrosis), and 25% of infants were found 
to have VUR of any grade.  
•	 	The performance of RUS in predicting VCUG was highly dependent on VUR 
grade.  In detecting any grade VUR, sensitivity, specificity, PPV and NPV 
were generally low.  In restricting analysis to grades III-V VUR only, RUS 
performance was not significantly better in any age group.  However, the 
optimal effectiveness of RUS as a screening tool was in detecting grades 
IV and V VUR only, with sensitivity and NPV of 100% in both neonates and 
older infants.  Table 2 summarizes the predictive characteristics of a RUS 
for detecting varying grades of VUR in neonates 0-2 months-old and older 
infants, 2-24 months-old. 
Conclusion:
•		As a screening tool, RUS demonstrated poor sensitivity, specificity, PPV and 
NPV for any grade of VUR, or for grades III, IV and V VUR in infants after initial 
UTI.  
•		Sensitivity and NPV are significantly increased when limited to the highest, and 
perhaps more clinically relevant, grade IV or V VUR only.  These results should 
be considered when applying the revised AAP UTI CPG.  
•		The performance of RUS as a screening tool appears to be similar in neonates 
as in older infants, suggesting that the scope of the AAP’s UTI CPG can include 
neonates.
Discussion:
Until the recent AAP UTI CPG revision, it had been standard practice to 
perform both a RUS and VCUG on infants after initial UTI to detect renal 
abnormalities that could predispose to recurrent infection and potential 
chronic renal disease.  More recently, concerns of increasing bacterial 
resistance7 and the overall effectiveness of prophylactic antibiotics8 in 
VUR have been raised, prompting the change in the AAP’s position to 
Table 1. Study Subject Characteristics
 Number(%)
Number of Subjects 
   Total 91 (100%)
   0-60 Days 39 (42.9%)
   2 months to 24 months 52 (57.1%)
Collection Method
   Straight Catheter 74 (81.3%)
   Clean Catch 4 (4.4%)
   Urine Bag 3 (3.3%)
   Not Specified 10 (11.0%)
CFU/ml
   10,000-50,000 cfu/ml 14 (15.4%)
   50,000-100,000 cfu/ml 5 (5.5%)
   >100,000 cfu/ml 68 (74.7%)
   Not Reported 4 (4.4%)
Bacterial species Isolated
   Escherichia coli 69 (75%)
   Enterobacter spp. 7 (7.6%)
   Group B Streptococcus 5 (5.4%)
   Klebsiella spp. 3 (3.3%)
   Enterococcus 3 (3.3%)
   MRSA 1 (1.1%)
   Not identified, other or        
   negative 4 (4.3%)
Renal Ultrasound
   Normal 54 (59.3%)
   Non-normal 37 (40.7%)
Highest VUR Grade
   No VUR 69 (75.8%)
   I 6 (6.6%)
   II 3 (3.3%)
   III 9 (9.9%)
   IV 1 (1.1%)
   V 3 (3.3%)
perform VCUG only after an abnormal RUS.  This has been controversial as the 
effectiveness of RUS as a screening tool has not been established.
We evaluated RUS as a screening tool for VUR in infants after their first UTI.  
Overall, sensitivity, specificity, PPV and NPV were low in both neonates and 
older infants.  This suggests that there will be a significant number of false-
negative RUS leading to undiagnosed VUR.  However, with effectiveness of 
prophylactic antibiotics still unresolved and the expectation that lower-grade VUR 
usually resolves spontaneously, then perhaps the benefit of both detection and 
prophylactic antibiotics may be experienced with only the highest grades of VUR 
(e.g, III to V).  Although RUS was no better at detecting grades III to V VUR than 
any VUR, sensitivity and NPV increased to 100% for grades IV or V only in all age 
groups.  Therefore, RUS may be effective as a screening tool if future research 
demonstrates benefit of prophylactic antibiotics for only the highest grades of VUR.  
Additionally, because the predictive characteristics for RUS were similar in both 
neonates and older infants, a further finding of this study suggests that current AAP 
recommendations can be extended to neonates 0-2 months old.
